Patent details

EP2269604 Title: Treatment of solid kidney tumours with a rapamycin derivative

Basic Information

Publication number:
EP2269604
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP101749851
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treatment of solid kidney tumours with a rapamycin derivative
French Title of Invention:
Traitement de tumeurs solides rénales avec un dérivé de la rapamycine
German Title of Invention:
Behandlung von soliden Nierentumoren mit einem Rapamycin-Derivat
SPC Number:
93320

Dates

Filing date:
18/02/2002
Grant date:
27/07/2016
EP Publication Date:
27/07/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2011
EP B1 Publication Date:
27/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/02/2022
Renunciation date:
Revocation date:
29/07/2021
Annulment date:

Owner

From:
13/11/2020
 
 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:
10/06/2020
To:
13/11/2020

Name:
NOVARTIS PHARMA AG
Address:
Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

From:
13/03/2019
To:
10/06/2020

Name:
NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
18/02/2002
To:
13/03/2019

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
O'Reilly Terence
Address:
Switzerland (CH)

2

Name:
Wood Jeanette Marjorie
Address:
Switzerland (CH)

3

Name:
Lane Heidi
Address:
Switzerland (CH)

Licencee

Name:
N.V. Novartis Pharma S.A.
From:
27/03/2019
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)
To:

Priority

1

Priority Number:
0104072
Priority Date:
19/02/2001
Priority Country:
United Kingdom (GB)

2

Priority Number:
0124957
Priority Date:
17/10/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 45/06;

Publication

Bulletin

1

Bulletin Heading:
MED
Bulletin edition number:
2019/06
Publication date:
06/05/2019
Description:
Section K : Modifications and recordals into the register

2

Bulletin Heading:
CO
Bulletin edition number:
2019/05
Publication date:
11/04/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
CO
Bulletin edition number:
2020/08
Publication date:
13/07/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

4

Bulletin Heading:
VRV
Bulletin edition number:
2021/13
Publication date:
02/12/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201722
Publication date:
31/05/2017
Description:
Opposition procedure started

2

Issue number:
202051
Publication date:
16/12/2020
Description:
Transfer of Rights

3

Issue number:
202147
Publication date:
24/11/2021
Description:
Revocation of the European patent

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20190000121A
Date Registered:
13/03/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC20190000139D
Date Registered:
27/03/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Not Exclusive
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Luxembourg (LU)
Updated Licence Number:
Terminated Licence Number:

Added Licencee(s)

Name:
N.V. Novartis Pharma S.A.
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000167A
Date Registered:
10/06/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NOVARTIS PHARMA AG
Address:
Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/02/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
13/03/2019 Request For Change 6
21/03/2019 Outgoing Correspondence 2
01/04/2019 Outgoing Correspondence 1
27/03/2019 Request For Change 6
10/06/2020 Request For Change 12